We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+19.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$865M
AUM Growth
-$24M
Cap. Flow
-$88.9M
Cap. Flow %
-10.28%
Top 10 Hldgs %
41.4%
Holding
250
New
65
Increased
30
Reduced
22
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 13.55%
2 Healthcare 13.49%
3 Financials 12.51%
4 Consumer Discretionary 8.44%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGN
151
DELISTED
MSG Networks Inc.
MSGN
$200K 0.02%
+11,500
New +$191K
CORT icon
152
Corcept Therapeutics
CORT
$12.2B
$177K 0.02%
14,600
FMCIW
153
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$170K 0.02%
368,900
BRSL
154
Brightstar Lottery PLC
BRSL
$2.06B
$165K 0.02%
11,000
-2,543
-19% -$36.2K
VTIQW
155
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$165K 0.02%
279,200
ADNWW
156
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$130K 0.02%
418,600
NEBUW
157
DELISTED
Nebula Acquisition Corporation Warrant
NEBUW
$116K 0.01%
93,031
LATNW
158
DELISTED
Union Acquisition Corp. II Warrant
LATNW
$112K 0.01%
+293,700
New +$105K
VEON icon
159
VEON
VEON
$3.92B
$106K 0.01%
1,680
EVH icon
160
Evolent Health
EVH
$488M
$101K 0.01%
11,200
-7,500
-40% -$60.9K
ASLEW
161
DELISTED
AerSale Corp Warrants
ASLEW
$93K 0.01%
124,200
-160,100
-56% -$88.4K
ANDAR
162
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$68K 0.01%
243,600
GIX.WS
163
DELISTED
GigCapital2, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $11.50
GIX.WS
$65K 0.01%
+203,500
New +$58.3K
TKKSR
164
DELISTED
TKK Symphony Acquisition Corporation Right
TKKSR
$52K 0.01%
208,580
SNAXW
165
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$51K 0.01%
243,600
GIX.RT
166
DELISTED
GigCapital2, Inc. Rights, each exchangeable into one-twentieth of a share of Common Stock
GIX.RT
$51K 0.01%
+203,500
New +$62K
RVPHW
167
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$49K 0.01%
194,500
TRNE.WS
168
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
$47K 0.01%
49,500
AVPTW
169
DELISTED
AvePoint Inc Warrant
AVPTW
$46K 0.01%
+39,750
New +$44.5K
PIC.WS
170
DELISTED
Pivotal Investment Corporation II Redeemable Warrants, each whole warrant exercisable for shares of
PIC.WS
$43K 0.01%
+54,932
New +$48.9K
PAACR
171
DELISTED
Proficient Alpha Acquisition Corp. Rights
PAACR
$28K ﹤0.01%
+164,000
New +$28.8K
PAACW
172
DELISTED
Proficient Alpha Acquisition Corp. Warrant
PAACW
$25K ﹤0.01%
+164,000
New +$19.8K
FLLCR
173
DELISTED
Fellazo Inc. Right
FLLCR
$25K ﹤0.01%
+145,800
New +$25.8K
BRPM.WS
174
DELISTED
B. Riley Principal Merger Corp. Warrants, each whole warrant exercisable for one share of Class A co
BRPM.WS
$22K ﹤0.01%
26,550
-73,600
-73% -$47.9K
AGBAR
175
DELISTED
AGBA Acquisition Ltd Right
AGBAR
$18K ﹤0.01%
+87,800
New +$19.6K

Similar funds

Gabelli & Co Investment Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Gabelli & Co Investment Advisers held 250 positions worth $865M, down 2.7% from $889M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $88.9M in Q4 2019, closing 52 positions and reducing 22 holdings. Its most notable exit was Celgene Corp, an estimated $54.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Tech Data Corp worth $26.2M.

  • Gabelli & Co Investment Advisers's largest Q4 2019 buy was Tech Data Corp: 182,273 shares worth $26.2M.
  • Gabelli & Co Investment Advisers added most to Tallgrass Energy, LP Class A Shares in Q4 2019, an estimated $19M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $2.42M.
  • Gabelli & Co Investment Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $54.1M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 41% of its $865M portfolio in Q4 2019.
  • Gabelli & Co Investment Advisers opened 65 new positions and closed 52 in Q4 2019.
  • Gabelli & Co Investment Advisers's portfolio value fell 2.7% quarter-over-quarter to $865M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.